Michael Heffernan, R. Ph

2016

In 2016, Michael Heffernan, R. Ph earned a total compensation of $2.2M as Founder and Chairman at Collegium Pharmaceutical.

Compensation breakdown

Non-Equity Incentive Plan$221,331
Option Awards$1,170,871
Salary$502,767
Stock Awards$290,644
Other$11,903
Total$2,197,516

Ph received $1.2M in option awards, accounting for 53% of the total pay in 2016.

Ph also received $221.3K in non-equity incentive plan, $502.8K in salary, $290.6K in stock awards and $11.9K in other compensation.

Rankings

In 2016, Michael Heffernan, R. Ph's compensation ranked 4,467th out of 14,075 executives tracked by ExecPay. In other words, Ph earned more than 68.3% of executives.

ClassificationRankingPercentile
All
4,467
out of 14,075
68th
Division
Manufacturing
1,575
out of 5,489
71st
Major group
Chemicals And Allied Products
478
out of 1,895
75th
Industry group
Drugs
350
out of 1,538
77th
Industry
Pharmaceutical Preparations
274
out of 1,176
77th
Source: SEC filing on March 15, 2019.

Ph's colleagues

We found five more compensation records of executives who worked with Michael Heffernan, R. Ph at Collegium Pharmaceutical in 2016.

2016

Michael Ph

Collegium Pharmaceutical

Chief Executive Officer

2016

Michael Heffernan

Collegium Pharmaceutical

Chief Executive Officer

2016

Paul Brannelly

Collegium Pharmaceutical

Chief Financial Officer

2016

Barry Duke

Collegium Pharmaceutical

Executive Vice President and Chief Commercial Officer

2016

Alison Fleming

Collegium Pharmaceutical

Chief Technology Officer

News

In-depth

You may also like